[Recent progress in the study of HIV-1 transcription factor NF-kappaB and its inhibitors]

Yao Xue Xue Bao. 2007 Oct;42(10):1007-12.
[Article in Chinese]

Abstract

Human immunodeficiency virus type 1 (HIV-1) transcription is a crucial step in the viral replication cycle, which is considered to be a potential target for inhibition of HIV-1 replication. Among the factors involved in this step, the cellular protein nuclear factor NF-kappaB is the most powerful inducer of HIV-1 transcription. HIV-1 transcription is initiated by the binding of NF-kappaB to the enhancer region in the long terminal repeat (LTR) of HIV-1. Several compounds suppress HIV-1 transcription through the inhibition of NF-kappaB activation. The mechanisms of NF-kappaB in the transcription of HIV-1 and progress of the current inhibitors of NF-kappaB are reviewed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-HIV Agents / pharmacology
  • HIV Long Terminal Repeat
  • HIV-1 / genetics*
  • Humans
  • I-kappa B Kinase / metabolism
  • I-kappa B Proteins / metabolism
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism*
  • Nicotinic Acids / pharmacology
  • Nitriles / pharmacology
  • Transcription, Genetic / drug effects*
  • Virus Replication

Substances

  • 2-amino-6-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-4-piperidin-4-yl nicotinonitrile
  • Anti-HIV Agents
  • I-kappa B Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • Nicotinic Acids
  • Nitriles
  • NF-KappaB Inhibitor alpha
  • I-kappa B Kinase